START FREE TRIAL

Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?

Pfizer just released mid-stage data from its Metsera-acquired obesity drug showing 12.3% weight loss at 28 weeks with monthly...

UnitedHealth CRASHES After Shocking Medicare Ruling — The Fallout Explained!

When a 0.09% number sends $96 billion out the window, you know something serious just happened. On January 27,...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...

Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets

If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle up. On January 15, the medtech...

AbbVie Trump Investment Deal: How Medicaid Cuts Bought Regulatory Peace!

AbbVie (NYSE:ABBV) just made a bold move—and the stakes are massive. The company agreed to invest $100 billion into...

Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off

Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...

Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!

If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!

Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...

Mirum Bluejay Acquisition Unlocks Rare Disease Gold!

Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...

Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?

Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...